Catalist

HC Surgical expands GP headcount by acquiring 25% stake in The Ming Clinic operator

SINGAPORE (May 31): HC Surgical Specialists, the Catalist-listed medical services provider, is acquiring a 25% stake in Medistar Services for $480,000 from three general practitioners (GPs), namely: Tan Hooi Wa, Roger Pang Heng Mun and Wong Yik Mun.

HC Surgical’s own GP, Lai Junxu, is also acquiring an additional 5% of share capital in Medistar.

Medistar operates a GP clinic, The Ming Clinic, at Camden Medical Centre.

Natural Cool makes foray into F&B industry with million-dollar acquisition

SINGAPORE (Feb 19): Natural Cool Holdings, the air-conditioning and switchgear specialist, is venturing into the food and beverage (F&B) industry by acquiring the business and assets of Yummy YM and SFB Global for $0.98 million.

Yummy and SFB Global are the manufacturers, distributors and retailers of cooked-food products and beverages & confections, respectively.

The former company is 70% owned by Leong Yew Meng, who is also the sole director and shareholder of SFB Global.

Grand Venture Technology public tranche 15.7 times subscribed; trading starts on Wed

SINGAPORE (Jan 22): Grand Venture Technology (GVT) says its $13.2 million initial public offering (IPO), which closed on Monday at 12 noon, successfully placed out all 42.9 million of its new shares at 27.5 cents.

The placement, comprising 0.8 million offer shares and 42.1 million placement shares, was fully subscribed in aggregate at 1.3 times.  

Trading of GVT’s shares on the SGX Catalist board is expected to start at 9am on Wednesday.

Why Mak Yuen Teen's latest study is causing such a stir among market watchers

SINGAPORE (Jan 18): On Tuesday, corporate governance advocate Mak Yuen Teen, an associate professor of accounting at the NUS Business School, released a study arguing that the reputation of the Catalist board has been hurt by recent transfers of underperforming companies from the Mainboard.

Corporate governance advocate urges SGX to relook rules allowing companies to transfer to Catalist

SINGAPORE (Jan 15): Corporate governance advocate Mak Yuen Teen and undergraduate Mark Lai have published a study urging the Singapore Exchange (SGX) to consider disallowing companies from transferring from the Mainboard to Catalist.

SGX in Jan 2016 had clarified and tightened the criteria for transfers from the Mainboard to Catalist, especially for loss-making companies. But Mak and Lai say the changes might not have been effective.

Medinex placing out 30 million shares to raise $7.5 mil ahead of Catalist listing

SINGAPORE (Dec 1): Medinex, the provider of professional support services to medical clinics, is selling 30 million shares at $0.25 each to raise $7.5 million.

This is ahead of its listing on the Catalist board of the Singapore Exchange.

Medical support services provider Medinex seeks Catalist listing in all-placement deal

Cennerv lodges prelim offer documents for Catalist listing, to acquire US subsidiary with proceeds

SINGAPORE (Sept 21): Cennerv Pharmaceuticals on Wednesday lodged its preliminary prospectus ahead of its planned initial public offering (IPO) on the SGX Catalist board.

Cennerv is a Singapore-based pharmaceutical developer specialising in treatments for central nervous system (CNS) disorders with a focus on depression, insomnia, dementia, schizophrenia and autism.

The company intends to use a portion of its proceeds from the exercise to acquire a further 13 million units of Gemeni Therapeutics LLC, a US-based drug development company, for US$200,000 ($272, 700).

SGX introduces new framework for listing of mineral and oil & gas firms at early development stages

SINGAPORE (July 24): The Singapore Exchange (SGX) is amending its Mainboard and Catalist listing rules for the mineral, oil and gas (MOG) sector, enabling companies at an earlier stage of development to list.  

The amended rules are effective Aug 23.

In a filing on Monday evening, the bourse says its new framework will reflect how the sector’s companies are catergorised based on each firm’s stage of development.

The Mainboard will continue to be for businesses that are more mature than those on Catalist, based on both asset development and size. 

Clearbridge BioMedics receives $6.6 mil in pre-IPO funding ahead of targeted 4Q launch

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.

The company expects to launch its IPO in 4Q18.

In a Thursday announcement, the clinical stage cancer diagnostics company says it intends to use its latest round of funds for business expansion, technology development, talent recruitment and IPO-related expenses to develop end-to-end cancer diagnostic tests.

Addvalue Technologies to spin off and list subsidiary via distribution in specie

SINGAPORE (June 12): Addvalue Technologies has released more details about the proposed spinoff and listing of wholly-owned subsidiary, Addvalue Solutions (AVS).

Addvalue Tech said the spinoff will be conducted through a distribution in specie to its shareholders of at least 10% of the shares of AVS currently held by the company via another wholly-owned subsidiary.

This will be followed by the listing and quotation of the AVS shares on the Catalist Board of the Singapore Exchange.

Be informed of the stories that matter